Difference between revisions of "Miriplatin (Miripla)"
Jump to navigation
Jump to search
(Created page with "Platinum agent used in TACE ==Diseases for which it is used== *Hepatocellular carcinoma ==History of changes in PMDA indication== *2009-10-16: Initial approval for lipiodo...") |
m (→Also known as) |
||
| Line 9: | Line 9: | ||
[[Category:Drugs]] | [[Category:Drugs]] | ||
| − | [[Category: | + | [[Category:Intra-arterial medications]] |
[[Category:Platinum agents]] | [[Category:Platinum agents]] | ||
Latest revision as of 21:16, 10 June 2023
Platinum agent used in TACE
Diseases for which it is used
History of changes in PMDA indication
- 2009-10-16: Initial approval for lipiodolization in hepatocellular carcinoma.
Also known as
- Brand name: Miripla